Home  >  Products  >  BCL2 (B-cell CLL/lymphoma 2) Blocking Peptide (the middle region of BCL2)(100ug)
BCL2 (B-cell CLL/lymphoma 2) Blocking Peptide (the middle region of BCL2)(100ug)

BCL2 (B-cell CLL/lymphoma 2) Blocking Peptide (the middle region of BCL2)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-BCL2 Antibody(ARP58872_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP58872
Size: 100ug
Weight: 26kDa
Gene: 596
Format: Lyophilized powder
Target: This gene encodes an integral outer mitochondrial membrane protein that blocks the apoptotic death of some cells such as lymphocytes. Constitutive expression of BCL2, such as in the case of translocation of BCL2 to Ig heavy chain locus, is thought to be the cause of follicular lymphoma. Two transcript variants, produced by alternate splicing, differ in their C-terminal ends.
Alternative names: Bcl-2
See Full Product Listings >